This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_OROPHARYNG_EXALLC for full statistics.
Malignant neoplasm of oropharynx
DOID EFO MESH Endpoint Browser
C3_OROPHARYNG
oropharynx cancer: A primary or metastatic malignant neoplasm that affects the oropharynx.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C10
Cause of death: ICD-9
146
Cause of death: ICD-8
146
Cause of death: excluded ICD-9
1460A
Cancer registry: Topography ICD-O-3
C10
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
30
Check minimum number of events None
30
Include endpoints None
30
Remove individuals based on genotype QC
30
C3_OROPHARYNG
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of oropharynx
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of oropharynx (controls excluding all cancers)
- Malignant neoplasm of oropharynx
- Malignant neoplasm of oropharynx (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 30 | 6 | 24 |
| Unadjusted prevalence (%) | 0.01 | 0.00 | 0.01 |
| Mean age at first event (years) | 65.39 | 63.84 | 65.78 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_OROPHARYNG – Malignant neoplasm of oropharynx
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of oropharynx
↥Endpoint not on priority list, no data to show.